RxDoctor Payments Data

Joy Curry, NP

Adult Health · Durham, NCNPI 1619204245

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (44.0%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Pfizer at 35.4% of the total. Among adult health clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,772in general payments, 2019–2025

Across 26 payments — averaging $183.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$2K
  • Global Blood Therapeutics, Inc.$2K
  • AstraZeneca$414
  • GSK$341
  • Sanofi$179
  • Novartis$120
  • plus $486 from 5 others

What the payments were for

  • Speaking & faculty fees$1,32328%
  • Travel & lodging$1,35028%
  • Food & beverage$2,09944%

General payments by program year

22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,772 in reported general payments places this provider in the 90th percentile of 614 adult health providers in North Carolina.

See all adult health providers in North Carolina

Medicare billing

Part B allowed, 2024
$38,927
Medicare patients
83
Services billed
2,099

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxbrytaVoxelotor14$174,435
EliquisApixaban46$34,946
NexiumEsomeprazole Magnesium12$6,649
Deferasirox16$6,286
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl22$3,702
Morphine Sulfate ErMorphine Sulfate45$3,406
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen66$2,830
Fentanyl29$2,801
Oxycodone Hcl158$2,334
Morphine Sulfate23$1,338
Naloxone Hcl21$1,310
Methadone Hcl44$1,042
Celecoxib35$943
Hydromorphone Hcl31$611
Amitriptyline Hcl27$594

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Global Blood Therapeutics, Inc.Oxbryta$1,543$174,43514 claims
PfizerEliquis$1,688$34,94646 claims
AstraZenecaNexium$414$6,64912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 614 adult health providers in North Carolina.

Other adult health in Durham

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →